Fluence map analyzer reduces low dose volume in locally advanced post mastectomy breast cancer patients


Uǧurlu B. T., Türk A., Celasun M. G., Hekimoglu A.

Biomedical Physics and Engineering Express, vol.8, no.3, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1088/2057-1976/ac584e
  • Journal Name: Biomedical Physics and Engineering Express
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Compendex, EMBASE, INSPEC, MEDLINE
  • Keywords: breast cancer, dose-spillage, fluence map, IMRT, integral dose
  • Kütahya Health Sciences University Affiliated: Yes

Abstract

© 2022 IOP Publishing Ltd.Multi-leaf collimator dose leakage in intensity-modulated radiotherapy (IMRT) plans causes higher low dose volume which increases the long-term risks of radiotherapy. We have developed Fluence Map Analyzer (FMA) program that suggests the ideal field geometry to reduce low dose volume in locally advanced breast cancer IMRT plans. In this comparative experimental study, FMA has been applied to standard IMRT plans (STD-IMRT) of randomly selected 15 left and 15 right-sided locally advanced breast cancer patients. All patients underwent a modified radical mastectomy. The chest wall, IMN, axillary, and supraclavicular lymph nodes are included in planning target volume (PTV). The heart, lungs, contralateral breast, and medulla spinalis were delineated as organs at risk (OARs). Two sets of plans, namely STD-IMRT and FMA-IMRT, were generated for each patient. The dosimetric analysis was performed using dose-volume histogram (DVH) and standard evaluation parameters of PTV and OARs. No differences could be observed among the two techniques for PTV coverage. However, FMA-IMRT plans achieved significantly lower V5 volumes and mean doses of the heart, lungs, contralateral breast, and body contours. FMA-IMRT used a smaller number of sub-fields and fewer monitor units (MU). FMA automizes the field geometry determination process for locally advanced breast cancer IMRT planning while reducing low dose volume significantly.